US18914F1030
US18914F1030
Clover Health Investments, Corp
Loading chart...
Pure Price Volatility Risk (Market Swings)
The business itself is financially solid (Financial Health 65/100, minimal insolvency risk). The high overall score (7/7) is driven primarily by extreme stock price swings (±75.5% p.a.) and steep historical drawdowns.
Volatility Risk
Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.
Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta
Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves approx. 2.5x as much as the broader market.
Beta (Market Relation)
2.46x
Above averageVolatility (5Y p.a.)
75.5% p.a.
5-Year HorizonMax Drawdown (5Y)
-92.3%
5-Year HorizonSharpe Ratio
-0.17
Return / RiskSpeculative / High Risk: Score Basis:
Multi-Horizon Risk & Performance Matrix
Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.
Stable Long-Term Volatility High Volatility
Timeframe | Volatility (p.a.) | Max Drawdown | Sharpe Ratio | Return (p.a.) |
|---|---|---|---|---|
| 1 Year | — | — | — | +64.7% |
| 3 Years | 72.8% | -64.7% | 0.82 | +62.4% |
| 5 Years | 75.5% | -92.3% | -0.17 | -10.2% |
| 10 Years | — | — | — | — |
Automated Risk & Health Notes (Red Flags)
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Unprofitable business model: The company is currently generating net losses.
High market risk: Beta of 2.46 indicates above-average volatility compared to the broader market.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (75.5% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -92.3% in the extended horizon.
Corporate Governance & ISS Scores
Overall Governance Risk
9 ISS Score: 9 / 10
Audit Risk
7 ISS Score: 7 / 10
Board Risk
8 ISS Score: 8 / 10
Short Ratio
5.87